News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Daily News Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis Yael L. Maxwell February 27, 2025
Presentation TCT 2024 Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR) Presenter: Allan Schwartz October 30, 2024
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News CRT 2020 Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation Michael O'Riordan February 26, 2020
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Conference News ESC 2018 Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI Michael O'Riordan August 25, 2018
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017